News for 'Viral Research'

Covid may damage brain like Parkinson's disease

Covid may damage brain like Parkinson's disease

Rediff.com20 Jun 2022

COVID-19 patients commonly report symptoms such as brain fog, headaches, and insomnia, complications which are not new after a viral infection, the researchers said.

'New Covid surge is a seasonal wave but spreads faster'

'New Covid surge is a seasonal wave but spreads faster'

Rediff.com18 Mar 2024

'Seek medical help if after five days of the first symptom the fever has not subsided.'

Health worker tests positive as Kerala reports fifth Nipah case

Health worker tests positive as Kerala reports fifth Nipah case

Rediff.com14 Sep 2023

The government has ordered monoclonal antibody from Indian Council of Medical Research to treat the child. It is the only available anti-viral treatment for Nipah virus infection, though it has not been clinically proven yet.

Centre issues alert to states over Tomato Flu in children

Centre issues alert to states over Tomato Flu in children

Rediff.com24 Aug 2022

Centre has sent an advisory to states on HFMD (Hand Foot and Mouth Disease), commonly known as Tomato Flu, stating that it's a self-limiting illness targeting mostly young children aged 1-10 years and immune-compromised adults and no specific drug exists to treat it.

Study reveals how COVID-19 damages heart

Study reveals how COVID-19 damages heart

Rediff.com3 Oct 2022

The researchers noted that while COVID-19 and influenza are both severe respiratory viruses, they appeared to affect cardiac tissue very differently.

Arbitrage funds back in favour as market volatility boosts returns

Arbitrage funds back in favour as market volatility boosts returns

Rediff.com29 Mar 2023

Arbitrage funds have recorded net inflows for three months straight, after steep outflows for half a year before that. The trend changed as mutual fund (MF) schemes improved amid a rise in equity market volatility. Investors redeemed over Rs 31,000 crore from arbitrage schemes between June and November before putting in Rs 3,000 crore in the last three months, shows data from the Association of Mutual Funds in India (Amfi).

Dr Reddy's Lab-DRDO drug treats heart damage post-Covid, shows US study

Dr Reddy's Lab-DRDO drug treats heart damage post-Covid, shows US study

Rediff.com8 Nov 2022

A drug developed by the Defence Research and Development Organisation (DRDO) may reverse the heart damage caused by a protein in the SARS-CoV-2 virus, a study conducted in fruit flies and mice has found.

NIV isolates monkeypox virus, paves way for vaccine, diagnostic kit

NIV isolates monkeypox virus, paves way for vaccine, diagnostic kit

Rediff.com27 Jul 2022

The National Institute of Virology (NIV) in Pune under the ICMR has isolated the monkeypox virus from the clinical specimen of a patient, which can pave the way for development of diagnostic kits and vaccines against the disease, officials said on Wednesday.

Scientists identify 70 drugs that may fight COVID-19

Scientists identify 70 drugs that may fight COVID-19

Rediff.com26 Mar 2020

The identification of host dependency factors mediating virus infection may provide key insights into effective molecular targets for developing broadly acting antiviral therapeutics against SARS-CoV-2 and other deadly coronavirus strains, according to the researchers.

Govt wanted Rs 3 lakh cr from RBI ahead of 2019 polls: Ex-Deputy Guv

Govt wanted Rs 3 lakh cr from RBI ahead of 2019 polls: Ex-Deputy Guv

Rediff.com7 Sep 2023

The Reserve Bank (RBI) resisted a 'raid' planned by some in the government to extract Rs 2-3 lakh crore from its balance sheet in 2018 to meet populist spending in run-up to general elections, Viral Acharya, who was deputy governor at RBI at that time, has written.

Should you opt to buy stocks of Divis Labs?

Should you opt to buy stocks of Divis Labs?

Rediff.com21 Apr 2023

The stock of Divis Laboratories is up 10 per cent over the last couple of trading sessions on expectations that the worst is behind and the company could see a sequential growth in the March quarter of the 2022-23 financial year (Q4FY23). The stock witnessed the highest downgrades among Nifty50 index stocks with earnings cuts over a third after the Q3FY23 results. The company had posted a 32 per cent drop in revenues over the year ago quarter in Q3FY23 and 8 per cent sequentially, which was sharply lower than Street expectations.

How To Protect Yourself From Dengue

How To Protect Yourself From Dengue

Rediff.com12 Oct 2023

While there is no specific treatment for dengue, recovery primarily involves managing symptoms and preventing complications, says Dr Amit Sakaria.

Omicron survives much longer on plastic, skin: Study

Omicron survives much longer on plastic, skin: Study

Rediff.com26 Jan 2022

The yet-to-be peer-reviewed study, posted recently on the preprint repository BioRxiv, found that the Alpha, Beta, Delta, and Omicron variants exhibited more than two-fold longer survival on plastic and skin surfaces, than the Wuhan strain.

Heart, BP patients likely to be infected with COVID-19 again: Study

Heart, BP patients likely to be infected with COVID-19 again: Study

Rediff.com24 Jun 2020

Researchers from Huazhong University of Science and Technology in China assessed data on 938 COVID-19 patients from the country's Wuhan Union Hospital. They obtained information about residual symptoms in these patients, and the results of follow up tests for viral genetic material in their body after they were discharged.

COVID: Active cases tally below 1.50 lakh

COVID: Active cases tally below 1.50 lakh

Rediff.com27 Jul 2022

The number of people who have recuperated from the disease has gone up to 4,32,67,571.

Covid originated in animals at Wuhan market and spread to humans: Studies

Covid originated in animals at Wuhan market and spread to humans: Studies

Rediff.com28 Feb 2022

The first study used spatial analysis to show that the earliest known COVID-19 cases, diagnosed in December 2019, were centered on the Wuhan market.

Vaccine-generated antibodies no shield against Omicron, says study, booster a must

Vaccine-generated antibodies no shield against Omicron, says study, booster a must

Rediff.com2 Mar 2022

Antibodies produced by two doses of mRNA vaccines against the original and early variants of the SARS-CoV-2 virus wane substantially over time, and offer essentially no protection against Omicron, according to a study that highlights the importance of a booster dose.

Monsoon nearing, fear of lumpy skin disease in cattle resurfaces

Monsoon nearing, fear of lumpy skin disease in cattle resurfaces

Rediff.com17 Apr 2023

The Centre has issued an advisory to states to speed up the preventive vaccination process.

China compelling docs to hide Covid mortalities: Report

China compelling docs to hide Covid mortalities: Report

Rediff.com28 Jan 2023

COVID infections in China began to surge towards December end and hospitals began to fill up. Many patients did not find beds and were seen sleeping on floors. Even, funeral homes and crematoriums were completely filled, and bodies were seen in the queue for days.

Mixing different vaccines produces better immune response: Study

Mixing different vaccines produces better immune response: Study

Rediff.com7 Dec 2021

Following up first doses of the AstraZeneca or Pfizer vaccines with second doses of the Moderna or Novavax jabs generates robust immune response against COVID-19, according to a study published in The Lancet journal.

One in eight recoverees suffer from long Covid, says comprehensive Lancet study

One in eight recoverees suffer from long Covid, says comprehensive Lancet study

Rediff.com5 Aug 2022

One in eight adults who are infected with SARS-CoV-2 experience long term symptoms due to Covid-19, according to one of the most comprehensive studies on the viral disease to date published in The Lancet journal on Friday.

3.2 million Indians may have died from Covid: Study

3.2 million Indians may have died from Covid: Study

Rediff.com7 Jan 2022

About 3.2 million people could have died from Covid in India by September last year, six-seven times higher than reported officially, according to a study based on one independent and two government data sources.

Ayurveda doctor joins race for COVID-19 cure

Ayurveda doctor joins race for COVID-19 cure

Rediff.com8 May 2020

'If the trial succeeds, it will become the success of Ayurveda.' 'If it's a failure, it's my failure alone.'

Scientists break 'camouflage' of novel coronavirus

Scientists break 'camouflage' of novel coronavirus

Rediff.com26 Jul 2020

The researchers from the the University of Texas Health Science Center at San Antonio (UT Health San Antonio) in the United States said by enabling this modification, nsp10 protects the virus from host cell immune response.

COVID-19's current strain is more infectious than original: Study

COVID-19's current strain is more infectious than original: Study

Rediff.com3 Jul 2020

The researchers said D614G has a small but effective change in the 'spike' protein that protrudes from the surface of the virus, which it uses to enter and infect human cells.

ICMR approves TB machines for COVID-19 testing

ICMR approves TB machines for COVID-19 testing

Rediff.com10 Apr 2020

The ICMR has validated 'TruenatTM beta CoV test on TruelabTM workstation' and has recommended it as a screening test,the apex health research body said on Friday.

Is It Time To Invest In Silver?

Is It Time To Invest In Silver?

Rediff.com17 May 2023

The rally in silver may continue if the global economic recovery remains on course.

Zydus's India-made Covid vaccine gets emergency use approval

Zydus's India-made Covid vaccine gets emergency use approval

Rediff.com20 Aug 2021

This is the world's first DNA-based vaccine against the coronavirus, and this three-dose vaccine when injected produces the spike protein of the SARS-CoV-2 virus and elicits an immune response, which plays a vital role in protection from the disease as well as viral clearance

7 symptoms can be used to maximise Covid detection, says study

7 symptoms can be used to maximise Covid detection, says study

Rediff.com29 Sep 2021

A set of seven symptoms, considered together, can be used to maximise detection of COVID-19 in the community, according to a study.

Children are silent spreaders of coronavirus: Study

Children are silent spreaders of coronavirus: Study

Rediff.com20 Aug 2020

The study, published in the Journal of Pediatrics, also challenges the current hypothesis that because children have lower numbers of immune receptors for SARS-CoV2, the virus that causes COVID-19, this makes them less likely to become infected or seriously ill.

Omicron infects 70 times faster than Delta: Study

Omicron infects 70 times faster than Delta: Study

Rediff.com16 Dec 2021

However, the severity of illness is likely to be much lower, according to a study.

Study points to mental disorders up to one year after Covid infection

Study points to mental disorders up to one year after Covid infection

Rediff.com17 Feb 2022

Covid-19 is associated with an increased risk of mental health disorders, including anxiety, depression, substance use, and sleep disorders, up to one year after the viral infection, according to a US study.

Serum Institute gets DGCI nod to manufacture Sputnik V in India

Serum Institute gets DGCI nod to manufacture Sputnik V in India

Rediff.com4 Jun 2021

The Drugs Controller General of India (DCGI) has granted permission to the Serum Institute of India (SII) to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis with certain conditions, official sources said.

India records 18,855 new COVID-19 cases, 163 more deaths

India records 18,855 new COVID-19 cases, 163 more deaths

Rediff.com29 Jan 2021

The number of people who have recuperated from the disease has surged to 1,03,94,352, pushing the national COVID-19 recovery rate to 96.96 per cent, while the case fatality rate stands at 1.44 per cent.

Pharma funds: 'Enter with a horizon of 5-7 years or more'

Pharma funds: 'Enter with a horizon of 5-7 years or more'

Rediff.com14 Mar 2023

In contrast with their strong performance in 2020 and 2021, pharmaceutical and healthcare funds experienced a decline in 2022, with returns plummeting by an average 9.8 per cent. This trend has continued in the current year, with year-to-date return remaining in the negative (-4.9 per cent). In the past three months, pharma funds have been hit hard, experiencing a 7.9 per cent decline.

'India might not have a third wave'

'India might not have a third wave'

Rediff.com6 Oct 2021

'Between its natural immunity with Delta, in so many populations, and then getting on top of the vaccination (situation), I do not think India is going to have another bad wave.'

Study says coronavirus infects heart cells of patients

Study says coronavirus infects heart cells of patients

Rediff.com1 Jul 2020

"We not only uncovered that these stem cell-derived heart cells are susceptible to infection by novel coronavirus, but that the virus can also quickly divide within the heart muscle cells," said study co-author Arun Sharma from the Cedars-Sinai Board of Governors Regenerative Medicine Institute in the United States. "Even more significant, the infected heart cells showed changes in their ability to beat after 72 hours of infection," Sharma said.

Covid: Omicron, sub-lineages dominant variant in India

Covid: Omicron, sub-lineages dominant variant in India

Rediff.com6 Aug 2022

"The COVID-19 cases are rising, but hospitalization and deaths are still less," said sources.

Mouthwashes, oral rinses may inactivate Covid: Study

Mouthwashes, oral rinses may inactivate Covid: Study

Rediff.com20 Oct 2020

The findings, published in the Journal of Medical Virology, indicate that some of these products might be useful for reducing the viral load, or amount of virus, in the mouth after infection.

COVID: India records 11,610 new cases; recovery rate 97.33%

COVID: India records 11,610 new cases; recovery rate 97.33%

Rediff.com17 Feb 2021

According to the Indian Council of Medical Research, 20,79,77,229 samples have so far been tested for the viral disease in the country, including 6,44,931 on Tuesday.